2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

Autor: Mach, F, Baigent, C, Catapano, AL, Koskinas, KC, Casula, M, Badimon, L, Chapman, MJ, De Backer, GG, Delgado, V, Ference, BA, Graham, IM, Halliday, A, Landmesser, U, Mihaylova, B, Pedersen, TR, Riccardi, G, Richter, DJ, Sabatine, MS, Taskinen, MR, Tokgozoglu, L, Wiklund, O, Mueller, C, Drexel, H, Aboyans, V, Corsini, A, Doehner, W, Farnier, M, Gigante, B, Kayikcioglu, M, Krstacic, G, Lambrinou, E, Lewis, BS, Masip, J, Moulin, P, Petersen, S, Petronio, AS, Piepoli, MF, Pinto, X, Raber, L, Ray, KK, Reiner, Z, Riesen, WF, Roffi, M, Schmid, JP, Shlyakhto, E, Simpson, IA, Stroes, E, Sudano, I, Tselepis, AD, Viigimaa, M, Vindis, C, Vonbank, A, Vrablik, M, Vrsalovic, M, Gomez, JLZ, Collet, JP, European Soc Cardiology, European Atherosclerosis Soc

Publikováno v: European Heart Journal, 41(1), 111-188. OXFORD UNIV PRESS
EUROPEAN HEART JOURNAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::92c3c4ceca1dcf8470d39ee0369189c6
https://academic.oup.com/eurheartj/article/41/1/111/5556353

Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: Where we are now?

Autor: Liberopoulos, EN Elisaf, MS Tselepis, AD Archimandritis, A and Kiskinis, D Cokkinos, D Mikhailidis, DP

A large number of patients require antiplatelet therapy (mainly aspirin and/or clopidogrel). Recent studies suggest that the combination of these agents is useful in patients with acute coronary syndrome and after percutaneous coronary intervention w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::5e14ca8a8b9e8d6a3c7b9c828fec5820
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3098848

Acute nateglinide administration in subjects with type 2 diabetes: Effects on postprandial metabolism, coagulation, and fibrinolysis

Autor: Tentolouris, N Boutati, E Karambakalis, N Perea, D and Tselepis, AD Tsoukala, C Kyriaki, D Lourida, E and Anastasopoulou, I Karafoullidou, A Raptis, SA Katsilambros, N

Background and aim: Postprandial glycaemia and lipaemia are known risk factors for atherosclerosis in type 2 diabetes. Coagulation activation in the postprandial. state also contributes to acceleration of atherosclerosis. Nateglinide is effective in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::b03c2747fb56399dda2a08944a0df35f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3093364

Glibenclamide improves postprandial hypertriglyceridaemia in Type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels

Autor: Skrapari, I Perrea, D Ioannidis, I Karabina, SAP Elisaf, M Tselepis, AD Karagiannacos, P Katsilambros, N

Aim There are scarce data dealing with the degree of postprandial lipaemia after sulphonylurea administration. The aim of this study was to examine the effect of acute glibenclamide administration on postprandial lipaemia in Type 2 diabetic patients.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::4da85081a638d1dc1c947393eb30fb3b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3080764

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.